J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mannila, A.
Right arrow Articles by Kokki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mannila, A.
Right arrow Articles by Kokki, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS

Plasma and Cerebrospinal Fluid Concentrations of Indomethacin in Children After Intravenous Administration

Anne Mannila, MSc, Elina Kumpulainen, BM, Marko Lehtonen, MSc, Marja Heikkinen, MD, Merja Laisalmi, MD, Terhi Salo, Jarkko Rautio, PhD, Jouko Savolainen, PhD and Hannu Kokki, MD, PhD

From the Department of Pharmaceutical Chemistry (Ms Mannila, Mr Lehtonen, Ms Salo, Dr Rautio, Dr Savolainen) and the Department of Pharmacology and Toxicology (Ms Kumpulainen, Dr Kokki), University of Kuopio, Finland, and the Department of Anaesthesiology and Intensive Care (Ms Kumpulainen, Dr Laisalmi, Dr Kokki) and the Department of Surgery (Dr Heikkinen), Kuopio University Hospital, Finland.

The objective of this study was to evaluate the cerebrospinal fluid (CSF) permeation of indomethacin in healthy children. The participants (n = 31, aged 4-144 months) received indomethacin (0.35 mg/kg) as a 10-minute intravenous infusion prior to surgery under spinal anaesthesia. A single CSF and plasma sample from each individual was collected 14 to 225 minutes after the infusion. Indomethacin concentrations were determined from the CSF, plasma, and protein-free plasma. Total plasma, protein-free plasma, and CSF concentrations of indomethacin ranged between 90 and 2200 ng/mL (median, 780 ng/mL), 0.3 and 0.8 ng/mL (median, 0.5 ng/mL), and 0.2 and 5.0 ng/mL (median, 1.4 ng/mL), respectively. The CSF to plasma concentration ratio remained less than 0.01. There was no correlation between the administration time and CSF concentrations. Eleven children developed 12 nonserious adverse effects, from which 5 were central nervous system (CNS) effects (agitation). In conclusion, indomethacin permeated into the CSF of children, which enables both desired and adverse CNS effects of indomethacin.


Key Words: Central nervous systemcerebrospinal fluidchildrenindomethacin

Address for reprints: Anne Mannila, Department of Pharmaceutical Chemistry, University of Kuopio, PO Box 1627, FI-70211 Kuopio, Finland.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Clin PharmacolHome page
E. Kumpulainen, H. Kokki, M. Laisalmi, M. Heikkinen, J. Savolainen, J. Rautio, and M. Lehtonen
How Readily Does Ketorolac Penetrate Cerebrospinal Fluid in Children?
J. Clin. Pharmacol., April 1, 2008; 48(4): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
H. Kokki, E. Kumpulainen, M. Lehtonen, M. Laisalmi, M. Heikkinen, J. Savolainen, and J. Rautio
Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children
Pediatrics, October 1, 2007; 120(4): e1002 - e1008.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Clinical Pharmacology